PHCH 512 - Roadmap to Drug Development

Institution:

University of Kansas

Subject:

AAAS: African & African-American Studies

Description:

This class will explore both the costs and time lines required for the approval of both new as well as generic drug products from identification of drug targets to FDA approval, and Phase 4 studies. Included will be a short history of the establishment of the FDA and its evolving role. The contributions of Frances Kelsey, the FDA scientist who fought the approval of thalidomide in the USA and thus saved many from the trauma of birth defects caused by the drug will be discussed. The class will be team taught by pharmaceutical chemistry faculty and guest speakers. Graded on a satisfactory/fail basis. Prerequisite: Completion of PHCH 626 or instructor permission. LEC

Credits:

1.00

Credit Hours:

Prerequisites:

Corequisites:

Exclusions:

Level:

Instructional Type:

Lecture

Notes:

Additional Information:

Historical Version(s):

Institution Website:

www.ku.edu/

Phone Number:

(785) 864-2700

Regional Accreditation:

North Central Association of Colleges and Schools

Calendar System:

Semester

The Course Profile information is provided and updated by third parties including the respective institutions. While the institutions are able to update their information at any time, the information is not independently validated, and no party associated with this website can accept responsibility for its accuracy.